Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports

17-02-2024 | Irritable Bowel Syndrome | Review

IBS and Chronic Prostatitis: Update on Chronic Pelvic Pain

Authors: Ehab Eltahawy, Nada Lelovic, Susanne Quallich, Bruno Machado

Published in: Current Bladder Dysfunction Reports

Login to get access

Abstract

Purpose of Review

The article aims to outline the pathogenesis, etiology, prevalence, and evaluation of chronic pelvic pain as it pertains to patients with two of the common causes: IBS and UCPPS.

Recent Findings

Because both diseases are diagnoses of exclusion, it is important to rule out other similar diagnoses. Biological markers are a new research frontier for identifying UCPP.

Summary

A careful and multimodal approach is then taken to address the patient’s goals and seek to optimize the QOL.
Literature
1.
2.
Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999;354(9182):936–9.PubMedCrossRef
3.
4.
Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel disorders. Gastroenterology. 2016;
5.
Frangenheim H, Kkeindienst W. Chronic pelvic disease of unknown origin. J Reprod Med. 1974;13(1):23–6.PubMed
6.
Shoskes DA, Nickel JC, Dolinga R, Prots D. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009;73(3):538–42. discussion 42-3PubMedCrossRef
7.
Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–7.PubMedCrossRef
8.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–21 e4.PubMedCrossRef
9.
Collins MM, Meigs JB, Barry MJ, Walker Corkery E, Giovannucci E, Kawachi I. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002;167(3):1363–6.PubMedCrossRef
10.
Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159(4):1224–8.PubMedCrossRef
11.
Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, Kimes T, Calhoun EA. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol. 2007;178(4 Pt 1):1333–7.PubMedCrossRef
12.
Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med. 2006;57:195–206.PubMedCrossRef
13.
Roberts RO, Lieber MM, Rhodes T, Girman CJ, Bostwick DG, Jacobsen SJ. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology. 1998;51(4):578–84.PubMedCrossRef
14••.
Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. J Urol. 2013;189(1):141–5. Population-based study estimated prevalence of chronic pelvic pain in men was 1.8%.PubMedCrossRef
15.
Dimitrakov J, Joffe HV, Soldin SJ, Bolus R, Buffington CA, Nickel JC. Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2008;71(2):261–6.PubMedCrossRef
16.
Clemens JQ, Brown SO, Kozloff L, Calhoun EA. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006;175(3 Pt 1):963–6. discussion 7PubMedCrossRef
17.
Lai HH, Thu JHL, Moh FV, Paradis A, Vetter J. Clustering of patients with interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2019;202(3):546–51.PubMedCrossRef
18.
Gasperi M, Krieger JN, Forsberg C, Goldberg J, Buchwald D, Afari N. Chronic prostatitis and comorbid non-urological overlapping pain conditions: a co-twin control study. J Psychosom Res. 2017;102:29–33.PubMedPubMedCentralCrossRef
19.
Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001;121(4):799–804.PubMedCrossRef
20.
Vehof J, Zavos HMS, Lachance G, Hammond CJ, Williams FMK. Shared genetic factors underlie chronic pain syndromes. Pain. 2014;155(8):1562–8.PubMedCrossRef
21.
Shoskes DA, Keslar KS, Gotwald P, Berglund R, Vij S. Neuroinflammatory gene expression in chronic prostatitis/chronic pelvic pain syndrome patients: insights into etiology and phenotype biology. Transl Androl Urol. 2021;10(8):3340–7.PubMedPubMedCentralCrossRef
22.
Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, et al. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2008;295(2):G219–25.PubMedPubMedCentralCrossRef
23.
Shoskes DA, Nickel JC, Rackley RR, Pontari MA. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis. 2009;12(2):177–83.PubMedCrossRef
24.
Nickel JC, Shoskes DA. Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2010;106(9):1252–63.PubMedCrossRef
25.
Nijs J, Meeus M, Van Oosterwijck J, Ickmans K, Moorkens G, Hans G, De Clerck LS. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur J Clin Invest. 2012;42(2):203–12.PubMedCrossRef
26.
Christianson JA, Liang R, Ustinova EE, Davis BM, Fraser MO, Pezzone MA. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain. 2007;128(3):235–43.PubMedCrossRef
27.
Bullones Rodriguez MA, Afari N, Buchwald DS, National Institute of D, Digestive, Kidney Diseases Working Group on Urological Chronic Pelvic P. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2013;189(1 Suppl):S66–74.PubMedPubMedCentral
28.
Russo J, Katon W, Sullivan M, Clark M, Buchwald D. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics. 1994;35(6):546–56.PubMedCrossRef
29.
Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome--a meta-analysis. Am J Gastroenterol. 2006;101(8):1894–9. quiz 942PubMedCrossRef
30.
Pontari M, Giusto L. New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome. Curr Opin Urol. 2013;23(6):565–9.PubMedCrossRef
31.
Tanaka Y, Yamashita R, Kawashima J, Mori H, Kurokawa K, Fukuda S, et al. Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation. J Gastroenterol. 2022;57(10):748–60.PubMedPubMedCentralCrossRef
32.
Pontari MA. Etiology of chronic prostatitis/chronic pelvic pain syndrome: psychoimmunoneurendocrine dysfunction (PINE syndrome) or just a really bad infection? World J Urol. 2013;31(4):725–32.PubMedCrossRef
33.
Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162(2):369–75.PubMedCrossRef
34.
Masterson JM, Castaneda PR, Kim J. Pathophysiology and Clinical biomarkers in interstitial cystitis. Urol Clin North Am. 2023;50(1):39–52.PubMedCrossRef
35.••
Bryk DJ, Shoskes DA. Using the UPOINT system to manage men with chronic pelvic pain syndrome. Arab. J Urol. 2021;19(3):387–93. UPOINT system approach allowed significant benefit based on phenotype.
36.
Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208(1):34–42.PubMedCrossRef
37.
Patcharatrakul T, Gonlachanvit S. Outcome of biofeedback therapy in dyssynergic defecation patients with and without irritable bowel syndrome. J Clin Gastroenterol. 2011;45(7):593–8.PubMedCrossRef
38.••
Fitzgerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2013;189(1 Suppl):S75–85. Randomized trial showed value of myofascial physical therapy.PubMedPubMedCentral
39.
Shahabi L, Naliboff BD, Shapiro D. Self-regulation evaluation of therapeutic yoga and walking for patients with irritable bowel syndrome: a pilot study. Psychol Health Med. 2016;21(2):176–88.PubMedCrossRef
40.
Camilleri M. Diagnosis and treatment of irritable bowel syndrome: a review. JAMA. 2021;325(9):865–77.PubMedCrossRef
41.
Shorter B, Ackerman M, Varvara M, Moldwin RM. Statistical validation of the shorter-moldwin food sensitivity questionnaire for patients with interstitial cystitis/bladder pain syndrome. J Urol. 2014;191(6):1793–801.PubMedCrossRef
42.
Dionne J, Ford AC, Yuan Y, Chey WD, Lacy BE, Saito YA, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol. 2018;113(9):1290–300.PubMedCrossRef
43.
Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, Mullin GE. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019;19(1):21.PubMedPubMedCentralCrossRef
44.
Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff T, Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology. 2001;57(3):422–7.PubMedCrossRef
45.
Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69(8):1441–51.PubMedCrossRef
46.
Drossman DA, Tack J, Ford AC, Szigethy E, Tornblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome Foundation Working Team Report. Gastroenterology. 2018;154(4):1140–71 e1.PubMedCrossRef
47.
van Ophoven A, Hertle L. Long-term results of amitriptyline treatment for interstitial cystitis. J Urol. 2005;174(5):1837–40.PubMedCrossRef
48.••
Qin Z, Zhang C, Guo J, Kwong JSW, Li X, Pang R, et al. Oral pharmacological treatments for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis of randomised controlled trials. EClinicalMed. 2022;48:101457. Network meta-analysis shows little evidence for efficacy of oral pharmacological treatments like antibiotics and alpha blockers in UCPPS.
49.
Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. alpha-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012;110(7):1014–22.PubMedCrossRef
50.
Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med. 2010;170(17):1586–93.PubMedPubMedCentralCrossRef
51.
52.
Lindeke-Myers A, Hanif AM, Jain N. Pentosan polysulfate maculopathy. Surv Ophthalmol. 2022;67(1):83–96.PubMedCrossRef
53.
Chey WD, Drossman DA, Johanson JF, Scott C, Panas RM, Ueno R. Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2012;35(5):587–99.PubMedCrossRef
54.
Johnston JM, Kurtz CB, Macdougall JE, Lavins BJ, Currie MG, Fitch DA, et al. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology. 2010;139(6):1877–86 e2.PubMedCrossRef
55.
Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22–32.PubMedCrossRef
56.
Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS. Safety of Eluxadoline in patients with irritable bowel syndrome with diarrhea. Am J Gastroenterol. 2017;112(2):365–74.PubMedCrossRef
57.
Camilleri M, Ford AC. Pharmacotherapy for irritable bowel syndrome. J Clin Med. 2017;6(11)
58.
Kirk PS, Santiago-Lastra Y, Qin Y, Stoffel JT, Clemens JQ, Cameron AP. The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome. Neurourol Urodyn. 2018;37(6):2002–7.PubMedCrossRef
59.
Miller JL, Rothman I, Bavendam TG, Berger RE. Prostatodynia and interstitial cystitis: one and the same? Urology. 1995;45(4):587–90.PubMedCrossRef
60.
Beamer MR, Pinkhasov A, Kravchick S. Preoperative modified spermatic cord block predicts success in candidates for microscopic spermatic cord denervation. Urology. 2021;156:31–6.PubMedCrossRef
61.
62.
Parsons BA, Goonewardene S, Dabestani S, Pacheco-Figueiredo L, Yuan Y, Zumstein V, et al. The benefits and harms of botulinum toxin-A in the treatment of chronic pelvic pain syndromes: a systematic review by the European Association of Urology Chronic Pelvic Pain Panel. Eur Urol Focus. 2022;8(1):320–38.PubMedCrossRef
63.
Metadata
Title
IBS and Chronic Prostatitis: Update on Chronic Pelvic Pain
Authors
Ehab Eltahawy
Nada Lelovic
Susanne Quallich
Bruno Machado
Publication date
17-02-2024
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-024-00740-y